Current Evidence Cannot Determine Heart Failure Risk in Transgender People
A systematic review indicates that current evidence is insufficient to determine whether transgender status or gender-affirming hormone therapy alters heart ...
A systematic review indicates that current evidence is insufficient to determine whether transgender status or gender-affirming hormone therapy alters heart ...
A narrative review finds that gender-affirming hormone therapy raises specific neurological and perioperative risks that neurosurgeons are largely untrained to ...
A systematic review of 96 studies finds gender-affirming hormone therapy linked to distinct cardiometabolic changes in transgender women and men, ...
A new perspective in the Journal of General Internal Medicine argues that transgender adults face elevated cardiovascular disease risk regardless ...
A pre-registered scoping review of 24 studies covering more than 5,500 transgender and gender-diverse people finds chronic pelvic and genital ...
The first systematic review and meta-analysis of pelvic pain in transmasculine individuals on testosterone finds a pooled prevalence of 39 ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.